Vilket är priset för Predictive Technology Group, Inc. (PRED)

Priset för Predictive Technology Group, Inc. (PRED) är $0.0001

Vilket är marknadsvärdet för Predictive Technology Group, Inc. (PRED)

Marknadsvärdet för Predictive Technology Group, Inc. (PRED) är $28.10K

Predictive Technology Group, Inc. (PRED) Pris och Marknadsvärde

Predictive Technology Group, Inc. (PRED), along with its affiliated companies, specializes in the creation and market introduction of cutting-edge molecular diagnostic and therapeutic solutions, as well as human cellular and tissue-based products (HCT/Ps). The company's operations are divided into two primary segments: Human Cellular and Tissue Products (HCT/Ps), and Diagnostics and Therapeutics. PRED offers genetic testing services like FertilityDX, which assists couples experiencing infertility, and ARTguide, a genetic test for women struggling with infertility often linked to endometriosis and other genetic conditions. In the realm of regenerative medicine, its product offerings include AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte. Furthermore, Predictive Technology Group has a cooperative arrangement with Atrin Pharmaceuticals LLC to advance molecular diagnostic tools, which are intended to refine the selection of patients for cancer treatments. Founded in 2005, the company initially operated under the name Global Enterprises Group, Inc., before rebranding to Predictive Technology Group, Inc. in July 2015. Its corporate headquarters are situated in Salt Lake City, Utah.

Pris för PRED	Tillgång B	Marknadsvärdet för B	Resultat
$19,450.75 $28.10K	NVDA	$5.466T	+19,450,749,174.16%
$15,937.62 $28.10K	AAPL	$4.479T	+15,937,619,848.25%
$14,858.76 $28.10K	GOOG	$4.176T	+14,858,764,877.39%
$13,128.99 $28.10K	MSFT	$3.690T	+13,128,990,880.77%
$10,255.76 $28.10K	AMZN	$2.882T	+10,255,757,723.58%

Pris för PRED

Tillgång B

Marknadsvärdet för B

Resultat

$19,450.75 $28.10K